U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606339) titled 'A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis' on May 19.
Brief Summary: The purpose of this study is to evaluate how long a participant keeps taking guselkumab or continues with their treatment plan without stopping (treatment persistence) in participants with moderate to severe Crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are inflammatory bowel diseases, a group of inflammatory conditions of the colon and small intestine.
Study Start Date: June 15
Study Type: OBSERVATIONAL
Condition:
Crohn Disease
Colitis, Ulcerative
Recruitment Status: NOT_YET_RECRUITING...